Avalo Therapeutics (AVTX) Finished Goods (2017 - 2019)
Avalo Therapeutics' Finished Goods was $46,705 in Q4 2019, down 90.6% from $497,949 a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Finished Goods (2017 - 2019) Analysis & Trends
- In earlier years, Finished Goods was $497,949 in FY2018 (-11.2%) and $560,499 in FY2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 46,705.00 |
| Dec 31, 2018 | 497,949.00 |
| Dec 31, 2017 | 560,499.00 |
API Access
Avalo Therapeutics Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();